Next Article in Journal / Special Issue
LDLR rs688 TT Genotype and T Allele Are Associated with Increased Susceptibility to Coronary Artery Disease—A Case-Control Study
Previous Article in Journal
Functional Significance of the Adcy10-Dependent Intracellular cAMP Compartments
Previous Article in Special Issue
Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
Article Menu

Export Article

Open AccessFeature PaperReview
J. Cardiovasc. Dev. Dis. 2018, 5(2), 30; https://doi.org/10.3390/jcdd5020030

Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation

Department of Surgery, University of California San Francisco & Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
*
Author to whom correspondence should be addressed.
Received: 12 April 2018 / Revised: 8 May 2018 / Accepted: 18 May 2018 / Published: 23 May 2018
(This article belongs to the Special Issue Lipoprotein Metabolism and Atherosclerosis)
Full-Text   |   PDF [1487 KB, uploaded 23 May 2018]   |  

Abstract

Apolipoprotein (apo) E stands out among plasma apolipoproteins through its unprecedented ability to protect against atherosclerosis. Although best recognized for its ability to mediate plasma lipoprotein clearance in the liver and protect against macrophage foam cell formation, our recent understanding of the influence that apoE can exert to control atherosclerosis has significantly widened. Among apoE’s newfound athero-protective properties include an ability to control exaggerated hematopoiesis, blood monocyte activation and aortic stiffening in mice with hyperlipidemia. Mechanisms responsible for these exciting new properties extend beyond apoE’s ability to prevent cellular lipid excess. Rather, new findings have revealed a role for apoE in regulating microRNA-controlled cellular signaling in cells of the immune system and vascular wall. Remarkably, infusions of apoE-responsive microRNA mimics were shown to substitute for apoE in protecting against systemic and vascular inflammation to suppress atherosclerosis in mice with hyperlipidemia. Finally, more recent evidence suggests that apoE may control the release of microvesicles that could modulate cellular signaling, inflammation and atherosclerosis at a distance. These exciting new findings position apoE within the emerging field of intercellular communication that could introduce new approaches to control atherosclerosis cardiovascular disease. View Full-Text
Keywords: apolipoprotein E; hyperlipidemia; atherosclerosis; inflammation; microRNA apolipoprotein E; hyperlipidemia; atherosclerosis; inflammation; microRNA
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Bouchareychas, L.; Raffai, R.L. Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation. J. Cardiovasc. Dev. Dis. 2018, 5, 30.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Cardiovasc. Dev. Dis. EISSN 2308-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top